Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial

Preventive Medicine

Volumn 50, Issue 5-6, 2010, Pages 297-299

  Hoffman, Richard M ^a,b   Steel, Susan ^a   Yee, Ellen F T ^a,b   Massie, Larry ^a,b   Schrader, Ronald M ^b   Murata, Glen H ^a,b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal neoplasms; Early detection of cancer; Medical records systems, computerized; Occult blood; Patient compliance; Randomized controlled trial

Indexed keywords

GUAIAC;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PATIENT SATISFACTION; PATIENT SELECTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VETERAN;

CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; ELECTRONIC HEALTH RECORDS; FECES; FEMALE; GUAIAC; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW MEXICO; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIMARY HEALTH CARE; REAGENT KITS, DIAGNOSTIC; STATISTICS, NONPARAMETRIC; VETERANS;

EID: 77952583613     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2010.03.010     Document Type: Article

References (10)

1. Cole S.R., Young G.P., Esterman A., Cadd B., Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J. Med. Screen 2003, 10:117-122.
2. Federici A., Rossi P.G., Borgia P., Bartolozzi F., Farchi S., Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J. Med. Screen 2005, 12:83-88.
3. Hewitson P., Glasziou P., Watson E., Towler B., Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am. J. Gastroenterol. 2008, 103:1541-1549.
4. Hol L., Wilschut J.A., van Ballegooijen M., et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br. J. Cancer 2009, 100:1103-1110.
5. Hughes K., Leggett B., Del Mar C., et al. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust. NZ J. Public Health 2005, 29:358-364.
6. Ko C.W., Dominitz J.A., Nguyen T.D. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am. J. Med. 2003, 115:111-114.
7. Levin B., Brooks D., Smith R.A., Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J. Clin. 2003, 53:44-55.
8. Seeff L.C., Manninen D.L., Dong F.B., et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology 2004, 127:1661-1669.
9. U.S.Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2008, 149:627-637.
10. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.